11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2020
-
Mark
Induction immunosuppression strategies and long-term outcomes after heart transplantation
(
- Contribution to journal › Article
-
Mark
Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial
(
- Contribution to journal › Article
- 2019
-
Mark
Time-dependent prognostic effects of recipient and donor age in adult heart transplantation
(
- Contribution to journal › Article
-
Mark
Continuous-flow LVADs in the Nordic countries : complications and mortality and its predictors
(
- Contribution to journal › Article
- 2017
-
Mark
Trends in the use of mechanical circulatory support as a bridge to heart transplantation across different age groups
(
- Contribution to journal › Article
-
Mark
Significance of Ischemic Heart Disease in Patients with Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction : A Nationwide Cohort Study
(
- Contribution to journal › Article
- 2016
-
Mark
Donor Age Associated with Short-Term and Recipient Age Associated with Long-Term Mortality in Heart Transplantation
2016) 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation In The Journal of Heart and Lung Transplantation 35(4 Suppl). p.114-115(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Prediction of Primary Graft Dysfunction After Heart Transplantation
2015) 35th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation In The Journal of Heart and Lung Transplantation 34(4). p.35-35(
- Contribution to journal › Published meeting abstract
-
Mark
Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »